News & Updates

Show Multimedia Only

Is ablation better than antiarrhythmic drugs for ventricular tachycardia?

29 Jan 2026 by

A substudy of the VANISH2 trial has found catheter ablation to be superior to sotalol in reducing ventricular tachycardia (VT) and VT-related events in sotalol-eligible patients. In those with more severe heart disease or VT storm, ablation demonstrates similar efficacy to amiodarone.

Is ablation better than antiarrhythmic drugs for ventricular tachycardia?

29 Jan 2026

Long COVID tied to lasting autonomic dysfunction

29 Jan 2026

Patients with long COVID may experience persistent autonomic dysfunction comparable to those with pure autonomic failure, reveals a study.

Long COVID tied to lasting autonomic dysfunction

29 Jan 2026

MACE risk lower with GLP1-RA vs DPP-4i in patients with kidney disease

29 Jan 2026

The use of glucagon-like peptide-1 receptor agonists (GLP1-RAs) better protects against major adverse cardiovascular events (MACE) as compared with dipeptidyl peptidase-4 inhibitors (DPP-4is) in patients across the spectrum of kidney disease, as shown in a retrospective study.

MACE risk lower with GLP1-RA vs DPP-4i in patients with kidney disease

29 Jan 2026

Omega‐3 provides some benefit in cardiovascular‐kidney‐metabolic syndrome

28 Jan 2026 by

In adults with cardiovascular‐kidney‐metabolic (CKM) syndrome, higher intake of omega‐3 polyunsaturated fatty acids (n‐3 PUFAs) has been associated with less severe CKM stage and lower mortality in new research.

Omega‐3 provides some benefit in cardiovascular‐kidney‐metabolic syndrome

28 Jan 2026

Successful endodontic Tx tied to cardiometabolic benefits

28 Jan 2026 by

In a self-controlled, longitudinal cohort study on individuals with apical periodontitis (AP), successful endodontic treatment is associated with improvements in glucose tolerance and lipid profile, suggesting a potential role in alleviating cardiometabolic disease risk.

Successful endodontic Tx tied to cardiometabolic benefits

28 Jan 2026

Bisoprolol makes no difference in moderately severe COPD

28 Jan 2026

In the treatment of patients with moderately severe chronic obstructive pulmonary disease (COPD), the use of bisoprolol has no significant effect on overall cardiorespiratory health, all-cause mortality, or serious cardiorespiratory events when compared with placebo, as shown in a phase III study.

Bisoprolol makes no difference in moderately severe COPD

28 Jan 2026

Is dairy a health food or a health risk?

26 Jan 2026 by

Consumption of dairy products does not appear to increase the risk of noncommunicable diseases or mortality, according to a scoping review of systematic reviews and meta-analyses.

Is dairy a health food or a health risk?

26 Jan 2026

SGLT2i use improves prognosis in T2D patients with coronary ischaemia

26 Jan 2026 by

Use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduces 3-year risks of major adverse cardiac events (MACE) and all-cause mortality in patients with type 2 diabetes (T2D) and coronary ischaemia, irrespective of the completeness of revascularization, researchers from the University of Hong Kong (HKU) have reported.

SGLT2i use improves prognosis in T2D patients with coronary ischaemia

26 Jan 2026

Aprocitentan shows worth in patients with resistant hypertension, CKD

25 Jan 2026 by

Aprocitentan appears beneficial in the treatment of patients with both resistant hypertension and chronic kidney disease (CKD), having been shown to improve blood pressure control and reduce urine albumin-to-creatinine ratio (UACR) when added to standardized background antihypertensive therapy.

Aprocitentan shows worth in patients with resistant hypertension, CKD

25 Jan 2026

Heart failure risk high in patients with systemic autoimmune inflammatory diseases

25 Jan 2026

Patients with systemic autoimmune inflammatory diseases—including systemic sclerosis, systemic lupus erythematosus (SLE), and rheumatoid arthritis (RA)—face an increased risk of heart failure (HF), as suggested in a retrospective study.

Heart failure risk high in patients with systemic autoimmune inflammatory diseases

25 Jan 2026

News & Updates

Showing Cardiology articles

Showing

Specialty:

Is ablation better than antiarrhythmic drugs for ventricular tachycardia?

Is ablation better than antiarrhythmic drugs for ventricular tachycardia?

Long COVID tied to lasting autonomic dysfunction

Long COVID tied to lasting autonomic dysfunction

MACE risk lower with GLP1-RA vs DPP-4i in patients with kidney disease

MACE risk lower with GLP1-RA vs DPP-4i in patients with kidney disease

Omega‐3 provides some benefit in cardiovascular‐kidney‐metabolic syndrome

Omega‐3 provides some benefit in cardiovascular‐kidney‐metabolic syndrome

Successful endodontic Tx tied to cardiometabolic benefits

Successful endodontic Tx tied to cardiometabolic benefits

Bisoprolol makes no difference in moderately severe COPD

Bisoprolol makes no difference in moderately severe COPD

Is dairy a health food or a health risk?

Is dairy a health food or a health risk?

SGLT2i use improves prognosis in T2D patients with coronary ischaemia

SGLT2i use improves prognosis in T2D patients with coronary ischaemia

Aprocitentan shows worth in patients with resistant hypertension, CKD

Aprocitentan shows worth in patients with resistant hypertension, CKD

Heart failure risk high in patients with systemic autoimmune inflammatory diseases

Heart failure risk high in patients with systemic autoimmune inflammatory diseases